Skip to content

Clinical trials

Phase 1 Carcinoma, Ovarian Epithelial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Phase: Phase 1 Clear all

185 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200011
200111
20024
20039
200413
20054
20065
20079
20083
20094
20107
20112
20126
20135
20144
20154
20164
20173
20195
20205
202110
202212
20233
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed124
Terminated26
Recruiting13
Unknown status8
Withdrawn6
Active, not recruiting5
Not yet recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)21
Memorial Sloan Kettering Cancer Center9
Gynecologic Oncology Group8
University of Washington6
City of Hope Medical Center5
Ludwig Institute for Cancer Research5
Case Comprehensive Cancer Center4
Fred Hutchinson Cancer Center3
Masonic Cancer Center, University of Minnesota3
Mayo Clinic3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial185
Ovarian Neoplasms91
Fallopian Tube Neoplasms72
Breast Neoplasms49
Carcinoma, Non-Small-Cell Lung45
Endometrial Neoplasms30
Pancreatic Neoplasms30
Stomach Neoplasms30
Neoplasms26
Prostatic Neoplasms26

Trials

Showing 51 to 75 of 185. Each trial links to its page on Pharma Observatory.

85 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.